Emerging Variant Capital
Emerging Variant Capital is a private equity investor based in New York, United States. It reports about $44m in private-fund assets across 1 private fund to the US Securities and Exchange Commission (Form ADV, October 2026). Its funds raised about $40m in the last 36 months (Form D filings).
Part of the 311 Institute Global Investors Directory (311institute.com). Last updated .
Other investors in United States
- New Mountain Capital
- Sixth Street
- Blackstone Life Sciences
- Macquarie Infrastructure Partners
- H.I.G. Capital
- Comvest Credit
- Court Square Capital
- Hamilton Lane
- Peak Rock Capital
- TPG Solutions
- Patient Square Capital
- Kleiner Perkins
Related
- Innovation profile of New York
- United States: economy and key statistics
- Global Startups Directory
- All 311 Indexes
Questions and answers
What kind of investor is Emerging Variant Capital?
Emerging Variant Capital is a private equity investor based in New York, United States.
Where is Emerging Variant Capital based?
Emerging Variant Capital is headquartered in New York, United States, according to its filing with the US Securities and Exchange Commission.
How much does Emerging Variant Capital manage?
It reports about $44m in private-fund assets across 1 private fund to the US Securities and Exchange Commission (Form ADV, October 2026).
Source: US Securities and Exchange Commission adviser record (Form ADV and Form D filings), as of October 2026.
© 311 Institute 2026. Facts from the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.